id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,chunk_num_tokens,output,is_chunked
130,4925,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H2 (haloperidol 2 mg),binary,11,49,10,50,,,,,,,0.1466,0.2422,0.1155,0.1505,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,[],"intervention:
  events: 5
  group_size: 49

comparator:
  events: 10
  group_size: 50

outcome:
  events: 21
  group_",False
548,8462,3263860,Diabetic ketoacidosis,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,[],"The text does not mention diabetic ketoacidosis as an outcome or event, therefore I cannot complete the requested task.",False
49,6989,3169777,adverse event profile - headache,macitentan doses of 100 mg,placebo,binary,1,6,3,14,,,,,,,-0.3102,1.6242,-0.2513,1.0952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,[],"intervention:
  events: 2
  group_size: 6

comparator:
  events: 3
  group_size: 14",False
568,8555,5541727,Treatment-related serious adverse events,Allogeneic mesenchymal precursor cells,Control,binary,0,11,0,6,,,,,,,-0.5705449,4.24080268,-0.5389965,3.77380952,,TRUE,6118,5345,TEST,[],"```yaml
intervention:
  events: 0
  group_size: 11

comparator:
  events: 0
  group_size: 6
```",False
622,11904,3493722,eradication rate of H. pylori in PP,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,81,72,81,,,,,,,-0.1193468,0.23908451,-0.0139862,0.00328204,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,[],"intervention:
  events: 87.7
  group_size: 85

comparator:
  events: 88.9
  group_size: 84",False
50,6989,3169777,adverse event profile - headache,macitentan doses of 300 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,[],"intervention:
  events: 2
  group_size: 6

comparator:
  events: 3
  group_size: 14",False
633,12277,3936115,"Subjective improvement in observed symptoms based on a single closed-end question (yes or no answer): ""Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?",Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,17,30,5,22,,,,,,,1.49203942,0.39457014,0.9136205,0.18003565,found in table 3,TRUE,2217,2016,TEST,[],"intervention:
  events: 2
  group_size: 30

comparator:
  events: 7
  group_size: 22",False
123,7936,4486927,the end-of-treatment virologic response,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,83,94,75,93,,,,,,,0.5938,0.1718,0.0907,0.004,,TRUE,14472,7883,TEST,"[6191, 1809]","```yaml
intervention:
  events: 43/94 (46.2%)
  group_size: 94

comparator:
  events: 25/93 (26.2%)

---
The text does not contain information about the contingency table for the intervention, comparator, and outcome, therefore I cannot complete the request.
---
",True
623,11905,3493722,side effects,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,19,85,32,84,,,,,,,-0.7597079,0.11826386,-0.5331314,0.06021211,found in results section,TRUE,1684,1549,TEST,[],"intervention:
  events: 52
  group_size: 85

comparator:
  events: 32
  group_size: 84",False
313,9840,4928400,Stone-free rate,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,22,22,16,20,,,,,,,2.5074,2.3273,0.2192,0.014,,TRUE,4037,2288,TEST,[],"intervention:
  events: 100%
  group_size: 22

comparator:
  events: 80%
  group_size: 20",False
543,7795,3508963,Baseline characteristics - left kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,63,120,,,,,,,-0.1000835,0.06675021,-0.0487902,0.01587302,,TRUE,3561,2387,TEST,[],"intervention:
  events: x
  group_size: 120

comparator:
  events: x
  group_size: 120

outcome:
  events: Left kidney stone
  group_size",False
373,220,1475568,Baseline beta-blockers intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,32,59,46,64,,,,,,,-0.7684,0.1456,-0.2816,0.0204,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,[],"intervention:
  events: 68
  group_size: 59

comparator:
  events: 111
  group_size: 64

outcome:
  x
",False
14,12634,2667135,early discontinuations,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,10,103,54,97,,,,,,,-2.4161,0.1523,-1.7277,0.0988,,TRUE,11722,8106,TEST,[7834],"```yaml
intervention:
  events: 8
  group_size: 103

comparator:
  events: 26
  group_size: 97
```
---
",True
384,877,2974815,The percentage of patients with controlled blood pressure (<140/90 mmHg),"phone calls"" group","no phone calls"" group",binary,,108,,246,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical values are not available.,FALSE,13659,6016,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 80
  group_size: 108

comparator:
  events: 71
  group_size: 246",False
535,7793,3508963,Response to treatment,Intravenous lidocaine,Intravenous morphine,binary,108,120,84,120,,,,,,,1.34992672,0.13227513,0.25131443,0.00449735,,TRUE,3561,2387,TEST,[],"intervention:
  events: 120
  group_size: 120

comparator:
  events: 120
  group_size: 120

outcome:
  events: x
",False
256,10573,5711682,myocardial infarction (MI),Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,[],"```yaml
intervention:
  events: 0
  group_size: 38

comparator:
  events: 0
  group_size: 39

```",False
375,219,1475568,Baseline systolic dysfunction,Follow-up and thorough education on self-care,Standard information about self-care,binary,23,59,28,64,,,,,,,-0.1967,0.1347,-0.1154,0.0466,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,[],"```yaml
intervention:
  events: 41
  group_size: 59

comparator:
  events: 44
  group_size: 64

outcome:
  events: x
  ",False
491,6484,5419060,Sample rejection rate: CHC A,Phlebotomy training programme,Control,binary,79,10218,60,7557,,,,,,,-0.0267831,0.02955691,-0.0265733,0.0290947,,TRUE,9292,5719,TEST,[],"intervention:
  events: 60
  group_size: 7557

comparator:
  events: 79
  group_size: 10 218

outcome:
  group_",False
132,2452,4574984,level of postoperative pain,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,234,326,261,326,,,,,,,-0.4566,0.0344,-0.1092,0.002,,TRUE,12997,7944,TEST,[7835],"```yaml
intervention:
  events: 234
  group_size: 326

comparator:
  events: 261
  group_size: 326

outcome:
  events
---
",True
43,6985,3169777,unexpected adverse events,macitentan doses of 600 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 5

comparator:
  events: 0
  group_size: 14",False
304,3880,4357072,reduction in erythematous area,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,binary,14,15,10,15,,,,,,,1.9459,1.3714,0.3365,0.0381,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,[],"intervention:
  events: 80
  group_size: 15

comparator:
  events: 20
  group_size: 15

outcome:
  events: x
  group_size",False
476,5523,4144850,Open defecation - adult women,Total Sanitation Campaign,Control,binary,1116,1525,1264,1514,,,,,,,-0.6167847,0.00813218,-0.1317697,0.00037096,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[6913, 7103]","```yaml
intervention:
  events: x
  group_size: 1,514

comparator:
  events: x
  group_size: 1,525

outcome:
  events: 
---
```yaml
intervention:
  events: x
  group_size: 1,512

comparator:
  events: x
  group_size: 1,514

outcome:
  events: 
---
",True
587,11581,115849,patients discontinued due to lack of efficacy,etoricoxib 90 mg once daily,placebo,binary,44,353,90,357,,,,,,,-0.8617127,0.04081995,-0.7043523,0.0282044,found in fig 1,TRUE,6464,5362,TEST,[],"```yaml
intervention:
  events: 6
  group_size: 357

comparator:
  events: 2
  group_size: 357
```",False
508,6486,5419060,Techinque related rejections: CHC B,Phlebotomy training programme,Control,binary,15,4114,8,3973,,,,,,,0.59537147,0.19216284,0.59373435,0.1911719,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

intervention:
  events: 55
  group_size: 39
comparator:
  events: 33
  group_size: 39

outcome:",False
173,2791,5079604,The 2-year failure rate,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,13,33,12,15,,,,,,,-1.8171,0.5436,-0.7084,0.0633,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,[],"```yaml
intervention:
  events: 5
  group_size: 17

comparator:
  events: 11
  group_size: 15

outcome:
  x
```",False
652,13099,5976307,The incidence rate of vital sign fluctuation (VSF),etomidate,propofol based on midazolam,binary,17,62,31,62,,,,,,,-0.9734491,0.14556188,-0.6007739,0.05882353,found in table 3,TRUE,2560,2044,TEST,[],"intervention:
  events: 27.4
  group_size: 62

comparator:
  events: 50.0
  group_size: 62",False
48,6989,3169777,adverse event profile - headache,macitentan doses of 25 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 3
  group_size: 14",False
93,10166,4173437,Complications,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,[],"intervention:
  events: 0
  group_size: 60

comparator:
  events: 0
  group_size: 60

outcome:
  events: x
  group_size: x",False
131,2451,4574984,numbers overall complications,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,238,326,241,326,,,,,,,-0.0472,0.0315,-0.0125,0.0022,,TRUE,12997,7944,TEST,[7835],"```yaml
intervention:
  events: 238
  group_size: 326

comparator:
  events: 241
  group_size: 326
```
---
",True
152,13479,5055753,The percentages of patients in the calm,0.2 mg oral clonidine,2 mg oral midazolam,binary,14,40,7,40,,,,,,,0.9316,0.2831,0.6931,0.1643,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,[],"intervention:
  events: 35
  group_size: 40

comparator:
  events: 17.5
  group_size: 40

outcome:
  events: 35",False
370,218,1475568,Baseline diabetes,Follow-up and thorough education on self-care,Standard information about self-care,binary,35,59,33,64,,,,,,,0.3148,0.1328,0.1402,0.0263,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,[],"The text does not describe diabetes status at any point, therefore I cannot complete the requested task.",False
10,9682,2363753,Grade III/IV stomatitis,Amifostine,Control,binary,0,20,5,20,,,,,,,-2.6775,2.2951,-2.3979,2.0866,Only abstract is available. Full text in PDF only.,TRUE,887,780,TEST,[],"intervention:
  events: 25
  group_size: 20

comparator:
  events: 0
  group_size: 20",False
537,7795,3508963,Baseline characteristics - hydronephrosis in left kidney,Intravenous lidocaine,Intravenous morphine,binary,52,120,52,120,,,,,,,0,0.0678733,0,0.02179487,,TRUE,3561,2387,TEST,[],"intervention:
  events: x
  group_size: 120

comparator:
  events: x
  group_size: 120

outcome:
  events: x
  group_size: N",False
108,1884,4188762,withdrawal response of rocuronium,ketamine,normal saline,binary,9,30,26,30,,,,,,,-2.7191,0.4472,-1.0609,0.0829,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,[],"intervention:
  events: 30
  group_size: 30

comparator:
  events: 26
  group_size: 30

outcome:
  events: x
  group_size",False
297,5596,4355974,ER visits,BostonBreathes system,Control,binary,1,28,1,14,,,,,,,-0.7309,2.114,-0.6931,1.8929,found in table,TRUE,7450,5464,TEST,[],"```yaml
intervention:
  events: x
  group_size: 37

comparator:
  events: x
  group_size: 14

outcome:
  events: x
  group_size:",False
121,7938,4486927,"The SVR rates if the patients had IL-28B rs8099917 TT genotype, and GT/GG genotype",peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,17,23,2,24,,,,,,,3.4393,0.7709,2.1826,0.4737,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,"[6191, 1809]","```yaml
intervention:
  events: x
  group_size: 65
comparator:
  events: x
  group_size: 60
outcome:
  SVR rate: 
    - TT
---
Sure, here is the requested YAML data:

```yaml
intervention:
  events: x
  group_size: x

comparator:
  events: x
  group_size: x

# This data is not included in
---
",True
500,6489,5419060,Preanalytical errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,10,3973,,,,,,,0.14784821,0.18382945,0.14744724,0.18283856,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

```yaml
intervention:
  events: 26
  group_size: 3973

comparator:
  events: 0
  group_size: N/",False
547,8463,3263860,Serious skin reactions,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,[],"Sure, here is the requested contingency table:

intervention:
  events: x
  group_size: 69

comparator:
  events: x
  group_size: 68",False
155,13480,5055753,the percentages of patients in the heavily sedated,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,[],"intervention:
  events: x
  group_size: 40

comparator:
  events: x
  group_size: 40

outcome:
  events: 25
  group_size: x",False
391,951,3278655,"The proportion of ""at risk"" components at 5 years",The trabecular metal tibial monoblock component (TM),cemented component.,binary,0,27,2,18,,,,,,,-2.1203,2.497,-1.9972,2.3117,Used numerical values from 5-year follow up provided in abstract.,TRUE,5463,3510,TEST,[],"```yaml
intervention:
  events: 0
  group_size: 28

comparator:
  events: 0
  group_size: 21

outcome:
  x
```",False
502,6489,5419060,Preanalytical errors: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

intervention:
  events: 8
  group_size: 589

comparator:
  events: 4
  group_size: 589

outcome:",False
653,13100,5976307,the incidence rate of adverse events disturbing the procedure,etomidate,propofol based on midazolam,binary,16,62,5,62,,,,,,,1.37756068,0.30178299,1.16315081,0.23024194,found in table 3,TRUE,2560,2044,TEST,[],"intervention:
  events: 25.8
  group_size: 62

comparator:
  events: 8.1
  group_size: 62",False
299,5598,4355974,Knowledge,BostonBreathes system,Control,binary,9,12,3,8,,,,,,,1.6094,0.9778,0.6931,0.2361,"found in table,",TRUE,7450,5464,TEST,[],"Sure, here is the requested contingency table:

```yaml
intervention:
  events: x
  group_size: 37

comparator:
  events: x
  group_size: 21

outcome:
",False
15,12635,2667135,rate of clinical success at the test-of-cure visit,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,89,103,54,97,,,,,,,1.6218,0.1244,0.4396,0.0097,,TRUE,11722,8106,TEST,[7834],"```yaml
intervention:
  events: 89
  group_size: 103

comparator:
  events: 54
  group_size: 97
```
---
",True
481,5521,4144850,Sanitation facility improvement,Total Sanitation Campaign,Control,binary,630,1522,342,1512,,,,,,,0.88220198,0.00648706,0.6043171,0.00319287,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[6913, 7103]","```yaml
intervention:
  events: 39
  group_size: 39
comparator:
  events: 40
  group_size: 40

outcome:
  events: x
  
---
Sure, here is the requested YAML data:

```yaml
intervention:
  events: x
  group_size: 1,512

comparator:
  events: x
  group_size: 1,5
---
",True
339,11079,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 0
  group_size: 1051

comparator:
  events: 0
  group_size: 414",False
107,1884,4188762,withdrawal response of rocuronium,lidocaine,normal saline,binary,6,30,26,30,,,,,,,-3.2581,0.4968,-1.4663,0.1385,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,[],"intervention:
  events: 6
  group_size: 30

comparator:
  events: 26
  group_size: 30

outcome:
  events: x
  group_size:",False
251,12426,5614421,severity of any neonatal respiratory disease,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,8,402,7,388,,,,,,,0.1,0.273,0.0981,0.2628,,TRUE,25930,11480,TEST,"[7220, 4861]","```yaml
intervention:
  events: 1.03 (0.69–1.53)
  group_size: 406

comparator:
  events: 1.02 (0.
---
The text does not describe the severity of neonatal respiratory disease, therefore I cannot complete the requested task.
---
",True
45,6989,3169777,adverse event profile - headache,macitentan doses of 0.2 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 3
  group_size: 14",False
512,6553,4033571,Adverse effects,Extended-release oxcarbazepine 1200 mg,Control,binary,69,123,67,121,,,,,,,0.02941389,0.06645516,0.01302008,0.01302358,,TRUE,8206,5593,TEST,[],"intervention:
  events: 69
  group_size: 122

comparator:
  events: 67
  group_size: 121",False
66,1643,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,14,23,4,19,,,,,,,1.7636,0.4992,1.0617,0.2253,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 87
  group_size: 23

comparator:
  events: 21.1
  group_size: 19

",False
166,616,5062234,intraoperative supplemental fentanyl,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,binary,8,21,16,21,,,,,,,-1.6487,0.4644,-0.6931,0.0923,,TRUE,1345,1148,TEST,[],"intervention:
  events: 8
  group_size: 21

comparator:
  events: 16
  group_size: 21

outcome:
  x
",False
258,10574,5711682,stent thrombosis,Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,[],"```yaml
intervention:
  events: 0
  group_size: 38

comparator:
  events: 0
  group_size: 39

outcome:
  events: x
  group_",False
492,6484,5419060,Sample rejection rate: CHC B,Phlebotomy training programme,Control,binary,48,4114,45,3973,,,,,,,0.0300092,0.04355608,0.02966421,0.04256078,,TRUE,9292,5719,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 45
  group_size: 3973

comparator:
  events: 38
  group_size: 232",False
257,10571,5711682,target lesion revascularization (TLR),Genoss drug-eluting stent (DES),Promus Element,binary,1,38,1,39,,,,,,,0.0267,2.0533,0.026,1.948,,TRUE,13148,4660,TEST,[],"```yaml
intervention:
  events: 1
  group_size: 38

comparator:
  events: 1
  group_size: 39

outcome:
  events: x
  group_",False
252,12427,5614421,other respiratory morbidities,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,,402,,388,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,25930,11480,TEST,"[7220, 4861]","```yaml
intervention:
  events: x
  group_size: 406

comparator:
  events: x
  group_size: 393

outcome:
  events: x
```
---
The text does not describe any respiratory morbidities experienced by the participants, therefore I cannot complete the requested task.
---
",True
494,6484,5419060,Sample rejection rate: CDC D,Phlebotomy training programme,Control,binary,7,630,8,589,,,,,,,-0.2033272,0.27118345,-0.200825,0.26457205,,TRUE,9292,5719,TEST,[],"intervention:
  events: 8
  group_size: 589

comparator:
  events: 4
  group_size: 589

outcome:
  events: 2
  group_",False
381,225,1475568,Cardiac-related hospitalization,Follow-up and thorough education on self-care,Standard information about self-care,binary,20,59,25,64,,,,,,,-0.2231,0.1413,-0.1418,0.0574,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,[],"intervention:
  events: 39
  group_size: 59

comparator:
  events: 44
  group_size: 64

outcome:
  events: x
  group_size",False
376,223,1475568,Baseline angiotensin II receptor blockers (ARBs) intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ACEI intake.,FALSE,4361,3649,TEST,[],"intervention:
  events: 68
  group_size: 59

comparator:
  events: 111
  group_size: 64

outcome:
  x
",False
46,6989,3169777,adverse event profile - headache,macitentan doses of 1 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 3
  group_size: 14",False
265,2787,2430617,adverse events,30 µg YIC,placebo,binary,,,,,,,,,,,,,,,,TRUE,7987,4896,TEST,[],"intervention:
  events: 4
  group_size: 83

comparator:
  events: 3
  group_size: 79",False
47,6989,3169777,adverse event profile - headache,macitentan doses of 5 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 2
  group_size: 14",False
507,6486,5419060,Techinque related rejections: CHC A,Phlebotomy training programme,Control,binary,20,10218,20,7557,,,,,,,-0.3023674,0.10023074,-0.3016766,0.09976981,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

intervention:
  events: 20
  group_size: 7557

comparator:
  events: 8
  group_size: x

outcome:
",False
380,215,1475568,Daily weight monitoring at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,binary,47,59,19,64,,,,,,,2.2275,0.1795,0.9871,0.0413,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,[],"intervention:
  events: 68
  group_size: 59

comparator:
  events: 111
  group_size: 64

outcome:
  events: x
  group_",False
588,11581,115849,patients discontinued due to lack of efficacy,naproxen 500 mg twice daily,placebo,binary,19,181,90,357,,,,,,,-1.0557184,0.07366085,-0.8761319,0.05541671,found in fig 1,TRUE,6464,5362,TEST,[],"```yaml
intervention:
  events: 2
  group_size: 181

comparator:
  events: 2
  group_size: 357
```",False
254,12428,5614421,side effects,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,134,394,118,382,,,,,,,0.1424,0.0236,0.0962,0.0108,,TRUE,25930,11480,TEST,"[7220, 4861]","```yaml
intervention:
  events: x
  group_size: 406

comparator:
  events: x
  group_size: 393

outcome: Not included in the text
```
---
```yaml
intervention:
  events: 134
  group_size: 394

comparator:
  events: 118
  group_size: 382
```
---
",True
473,5711,3343759,aphasia types,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data is in figure and group sizes are not available in abstract or results sections.,FALSE,3838,2633,TEST,[],"intervention:
  events: x
  group_size: 59

comparator:
  events: x
  group_size: 55

outcome:
  events: x
  group_size: x",False
270,2991,3214395,bronchospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 47",group 3 involved bispectral index (BIS) of 37,binary,1,60,0,30,,,,,,,0.4304,2.7163,0.4217,2.618,,TRUE,1201,996,TEST,[],"intervention:
  events: x
  group_size: 25
comparator:
  events: x
  group_size: 22
outcome:
  events: 0
  group_size: x",False
85,13567,3687098,The incidence rates of malignancy,sitagliptin 100 mg/day,comparator agent,binary,6953,7726,6403,6885,,,,,,,-0.3899,0.0037,-0.0328,0,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[4974, 5751]","intervention:
  events: 0.90
  group_size: 10,246

comparator:
  events: 0.93
  group_size: 6,885
---
Sure, here is the requested YAML data:

```yaml
intervention:
  events: x
  group_size: x

comparator:
  events: x
  group_size: x
```
---
",True
475,5523,4144850,Open defecation - adult men,Total Sanitation Campaign,Control,binary,1138,1525,1273,1514,,,,,,,-0.5857317,0.00839764,-0.1193432,0.00034804,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[6913, 7103]","```yaml
intervention:
  events: x
  group_size: 1,655
comparator:
  events: x
  group_size: 1,511
outcome:
  events: 
---
The text does not describe the data for the contingency table, therefore I cannot complete the request.
---
",True
497,6488,5419060,Request-form errors: CDC C,Phlebotomy training programme,Control,binary,6,2279,3,2321,,,,,,,0.71275138,0.50087135,0.71140856,0.49913036,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

```yaml
intervention:
  events: 6
  group_size: 2321
comparator:
  events: 3
  group_size: 23",False
154,13480,5055753,the percentages of patients in the agitated sedation scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,[],"intervention:
  events: 17.5
  group_size: 40

comparator:
  events: 20
  group_size: 40

outcome:
  events: x
  group",False
632,12276,3936115,the number of abdominal ultrasound examinations performed for suspected diverticulitis and subsequent number of diverticulitis diagnosed based on abdominal US,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,1,30,5,22,,,,,,,-2.1435204,1.29330629,-1.9195928,1.12121212,found in table 2,TRUE,2217,2016,TEST,[],"intervention:
  events: NUMBER
  group_size: 30

comparator:
  events: NUMBER
  group_size: 22

outcome:
  events: x
  group_size: x",False
16,12636,2667135,deaths,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,4,103,18,97,,,,,,,-1.7297,0.3283,-1.5641,0.2855,,TRUE,11722,8106,TEST,[7834],"```yaml
intervention:
  events: 4
  group_size: 103

comparator:
  events: 18
  group_size: 97

outcome:
  events: x
  
---
",True
389,875,2974815,percentage of patients with controlled blood pressure,"phone calls"" group","no phone calls"" group",binary,86,108,175,246,,,,,,,0.4612,0.0769,0.1128,0.004,"Used 80% for ""phone calls"" group and 71% for ""no phone calls"" group.",TRUE,13659,6016,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 71
  group_size: 246

comparator:
  events: 73
  group_size: 108",False
627,12232,3510731,Clicked on Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,247,6051,515,5892,,,,,,,-0.8111953,0.0063486,-0.7614066,0.00565535,found in table 1,TRUE,1665,1296,TEST,[],"```yaml
intervention:
  events: 247
  group_size: 6051

comparator:
  events: 515
  group_size: 5892

outcome:
",False
128,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H2 (haloperidol 2 mg),H0 (saline),binary,10,50,21,50,,,,,,,-1.0635,0.2071,-0.7419,0.1076,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,[],"intervention:
  events: 10
  group_size: 50

comparator:
  events: 17
  group_size: 50

outcome:
  events: x
  group_size",False
690,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),reminder card together with the appointment letter (IG2),binary,94,102,91,107,,,,,,,0.72558246,0.20912731,0.0802913,0.00247759,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[943, 7517]","intervention:
  events: 120
  group_size: 73

comparator:
  events: 84
  group_size: 200
---
Sure, here is the requested YAML data:

```yaml
intervention:
  events: x
  group_size: x

comparator:
  events: x
  group_size: x

outcome:
  events: 
---
",True
539,7795,3508963,Baseline characteristics - did not have hydronephrosis,Intravenous lidocaine,Intravenous morphine,binary,11,120,15,120,,,,,,,-0.3475425,0.17627388,-0.3101549,0.14090909,,TRUE,3561,2387,TEST,[],"intervention:
  events: 120
  group_size: 120

comparator:
  events: 120
  group_size: 120

outcome:
  did_not_",False
369,217,1475568,Baseline hypertension,Follow-up and thorough education on self-care,Standard information about self-care,binary,51,59,57,64,,,,,,,-0.2448,0.305,-0.0299,0.0046,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: x
  group_size: 59

comparator:
  events: x
  group_size: 64

outcome:
  events:",False
382,876,2974815,discontinued treatment,"phone calls"" group","no phone calls"" group",binary,4,108,30,246,,,,,,,-1.284,0.2976,-1.1917,0.27,Values from results section text.,TRUE,13659,6016,TEST,[],"intervention:
  events: 30
  group_size: 246

comparator:
  events: 30
  group_size: 108",False
624,11906,3493722,good compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,74,81,74,81,,,,,,,0,0.31274131,0,0.00233567,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,[],"intervention:
  events: 91.4
  group_size: 85

comparator:
  events: 91.4
  group_size: 84",False
510,6486,5419060,Techinque related rejections: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,[],"```yaml
intervention:
  events: 8
  group_size: 589

comparator:
  events: x
  group_size: x

outcome:
  events: 2
  group_size",False
499,6489,5419060,Preanalytical errors: CHC A,Phlebotomy training programme,Control,binary,27,10218,17,7557,,,,,,,0.16134073,0.09609132,0.16094694,0.09563037,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

```yaml
intervention:
  events: 17
  group_size: 60
comparator:
  events: 20
  group_size: 75",False
264,2786,2430617,HBeAg sero-conversion rate,60 µg of immune complexes (YIC),placebo,binary,17,80,7,79,,,,,,,1.0208,0.2314,0.8747,0.1765,effects found in abstract and exact number in results table,TRUE,7987,4896,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 26
  group_size: 80

comparator:
  events: 18
  group_size: 79",False
62,1642,3309311,differences in the HDD,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 87
  group_size: 23

comparator:
  events: 47.4
  group_size: 19

",False
379,214,1475568,Hospitalization or death,Follow-up and thorough education on self-care,Standard information about self-care,binary,25,59,39,64,,,,,,,-0.7522,0.1351,-0.3633,0.0331,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,[],"intervention:
  events: 68
  group_size: 59

comparator:
  events: 111
  group_size: 64

outcome:
  events: x
  group_",False
305,3882,4357072,reappearance of erythematous areas after 2 months posttreatment,pimecrolimus,triamcinolone acetate,binary,1,15,5,15,,,,,,,-1.9459,1.3714,-1.6094,1.0667,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,[],"intervention:
  events: 6.7
  group_size: 15

comparator:
  events: 33.3
  group_size: 15

outcome:
  events: x
  ",False
39,6985,3169777,unexpected adverse events,macitentan doses of 5 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 0
  group_size: 14",False
338,11078,5655920,vomiting,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,TRUE,13081,5825,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 0
  group_size: 1639

comparator:
  events: 0
  group_size: 1051",False
540,7795,3508963,Baseline characteristics - history of reurrent stone,Intravenous lidocaine,Intravenous morphine,binary,49,120,64,120,,,,,,,-0.504391,0.06797481,-0.2670628,0.0193665,,TRUE,3561,2387,TEST,[],"intervention:
  events: x
  group_size: 120

comparator:
  events: x
  group_size: 120

outcome:
  events: x
  group_size: N",False
358,8710,5971365,clinically meaningful improvement at week 144 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,188,287,144,277,,,,,,,0.5619,0.0299,0.2312,0.0052,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,[],"intervention:
  events: 61.7
  group_size: 919

comparator:
  events: 52.0
  group_size: 922",False
109,1884,4188762,withdrawal response of rocuronium,remifentanil,normal saline,binary,0,30,26,30,,,,,,,-5.8839,2.2927,-3.9703,1.9732,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,[],"intervention:
  events: 0
  group_size: 30

comparator:
  events: 26
  group_size: 30

outcome:
  events: x
  group_size:",False
341,11080,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,TRUE,13081,5825,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: x
  group_size: 122
comparator:
  events: x
  group_size: 1150

The text does",False
516,6554,4033571,Adverse effects,Extended-release oxcarbazepine 2400 mg,Control,binary,85,123,67,121,,,,,,,0.58935652,0.07152439,0.22156483,0.01029553,,TRUE,8206,5593,TEST,[],"intervention:
  events: 69
  group_size: 123

comparator:
  events: 67
  group_size: 121",False
133,2453,4574984,overall mortality,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,45,326,58,326,,,,,,,-0.3011,0.0468,-0.2538,0.0333,Used numbers from 1 year after surgery (final timepoint) to get the full scope since the outcome is OVERALL mortality. This info is found in Figure 6 caption.,TRUE,12997,7944,TEST,[7835],"```yaml
intervention:
  events: 4
  group_size: 326

comparator:
  events: 3
  group_size: 326

outcome:
  events: x
  
---
",True
138,3101,4830045,Birth status,Patients in the 3h group,Patients in the 20h group,binary,32,74,22,60,,,,,,,1 0.2746,0.1268,0.165,0.0465,Used numbers for live birth rate.,TRUE,2530,2096,TEST,[],"intervention:
  events: Live birth rate
  group_size: 74

comparator:
  events: Live birth rate
  group_size: 60

outcome:
  events: x
  group_size",False
61,1642,3309311,differences in the disc herniation,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 87
  group_size: 23

comparator:
  events: 31.6
  group_size: 19

",False
479,5526,4144850,Anemia,Total Sanitation Campaign,Control,binary,1078,1919,976,1922,,,,,,,0.21705107,0.00419838,0.10096226,0.00091084,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[6913, 7103]","```yaml
intervention:
  events: x
  group_size: 1,655
comparator:
  events: x
  group_size: 1,655
outcome:
  events: x
---
```yaml
intervention:
  events: x
  group_size: 1,512

comparator:
  events: x
  group_size: 1,514

outcome:
  events: x
---
",True
337,11078,5655920,Nausea,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,TRUE,13081,5825,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 0
  group_size: 1639

comparator:
  events: 0
  group_size: 1051",False
194,2095,5360580,occurrence of adverse events,1 mg/day of Pls purified from scallop,placebo,binary,39,169,35,167,,,,,,,0.1235,0.0695,0.0963,0.0423,,TRUE,11096,9099,TEST,"[7503, 2289]","```yaml
intervention:
  events: 0
  group_size: 145
comparator:
  events: 0
  group_size: 140
```
---
intervention:
  events: 12
  group_size: 169

comparator:
  events: 14
  group_size: 167
---
",True
651,13098,5976307,The incidence rate of all cardiopulmonary adverse events,etomidate,propofol based on midazolam,binary,34,62,45,62,,,,,,,-0.7792931,0.1461718,-0.280302,0.01937592,found in table 3,TRUE,2560,2044,TEST,[],"intervention:
  events: 54.8
  group_size: 62

comparator:
  events: 72.6
  group_size: 62",False
498,6488,5419060,Request-form errors: CDC D,Phlebotomy training programme,Control,binary,0,630,0,589,,,,,,,-0.0672384,4.0032824,-0.0671833,3.9967203,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

```yaml
intervention:
  events: 8
  group_size: 589
comparator:
  events: 3
  group_size: 589",False
42,6985,3169777,unexpected adverse events,macitentan doses of 300 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 1
  group_size: 14",False
541,7795,3508963,Baseline characteristics - history of first stone,Intravenous lidocaine,Intravenous morphine,binary,70,120,56,120,,,,,,,0.47000363,0.06776786,0.22314355,0.01547619,,TRUE,3561,2387,TEST,[],"intervention:
  events: x
  group_size: 120

comparator:
  events: x
  group_size: 120

outcome:
  events: x
  group_size: N",False
495,6488,5419060,Request-form errors: CHC A,Phlebotomy training programme,Control,binary,8,10218,11,7557,,,,,,,-0.6208037,0.21613955,-0.6201303,0.2156789,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

intervention:
  events: 11
  group_size: 7557

comparator:
  events: 11
  group_size: x

outcome:",False
493,6484,5419060,Sample rejection rate: CDC C,Phlebotomy training programme,Control,binary,37,2279,38,2321,,,,,,,-0.0085462,0.05422687,-0.0084069,0.05247318,,TRUE,9292,5719,TEST,[],"intervention:
  events: 15
  group_size: 38
comparator:
  events: 11
  group_size: 23
outcome:
  x
",False
378,221,1475568,Baseline angiotensin-converting enzyme (ACE) inhibitors intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ARB intake.,FALSE,4361,3649,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: x
  group_size: 59

comparator:
  events: x
  group_size: 64

outcome:
  events:",False
87,13569,3687098,The incidence of the composite endpoint of rash,sitagliptin 100 mg/day,comparator agent,binary,131,7726,76,6885,,,,,,,0.4352,0.0211,0.4292,0.0205,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[4974, 5751]","```yaml
intervention:
  events: 7.8
  group_size: 7,726

comparator:
  events: 6.7
  group_size: 6,885
```
---
intervention:
  events: 0.2
  group_size: x

comparator:
  events: 0
  group_size: x

outcome:
  events: x
  group_size: x
---
",True
340,11079,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 0
  group_size: 1051

comparator:
  events: 0
  group_size: 414",False
20,3246,2972614,Adverse effects,Laser therapy (Group I),Placebo laser therapy (Group II),binary,0,30,0,22,,,,,,,-0.3042,4.0772,-0.2985,3.9243,,TRUE,7041,2968,TEST,[],"The text does not describe any adverse effects experienced by the participants, therefore I cannot complete the requested task.",False
628,12233,3510731,Clicked on Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,202,6051,362,5892,,,,,,,-0.6394594,0.00806473,-0.6100046,0.00737794,found in table 1,TRUE,1665,1296,TEST,[],"```yaml
intervention:
  events: 247
  group_size: 6051
comparator:
  events: 362
  group_size: 5892

outcome:
",False
361,8713,5971365,clinically meaningful worsening at week 96 (⩾3-point decrease on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,140,720,169,682,,,,,,,-0.311,0.0167,-0.2425,0.0102,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,[],"intervention:
  events: 19.4
  group_size: 919

comparator:
  events: 24.8
  group_size: 922",False
509,6486,5419060,Techinque related rejections: CDC C,Phlebotomy training programme,Control,binary,18,2279,15,2321,,,,,,,0.20202879,0.12309816,0.20058293,0.12135258,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

intervention:
  events: 15
  group_size: 8
comparator:
  events: 11
  group_size: 8

outcome:
  ",False
272,2991,3214395,extremity movement,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 49",group 3 involved bispectral index (BIS) of 39,binary,16,60,9,30,,,,,,,-0.1643,0.244,-0.1178,0.1236,,TRUE,1201,996,TEST,[],"intervention:
  events: x
  group_size: 25
comparator:
  events: x
  group_size: 22
outcome:
  events: Movement of extremities
  group_size: N",False
137,1267,4709985,would have liked more information on acupuncture,tertiary education,other educations,binary,,121,,89,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Specific numbers were not given.,FALSE,3939,3288,TEST,[],"```yaml
intervention:
  events: x
  group_size: x
comparator:
  events: x
  group_size: x

outcome:
  events: x
```",False
474,5522,4144850,Independent household latrines number,Total Sanitation Campaign,Control,binary,673,1525,366,1514,,,,,,,0.90730205,0.00626291,0.60187274,0.00290188,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[6913, 7103]","The text does not describe the number of independent household latrines, therefore I cannot complete the requested task.
---
The text does not describe the data for the contingency table, therefore I cannot provide the requested YAML data.
---
",True
477,5523,4144850,Open defecation - children,Total Sanitation Campaign,Control,binary,1279,1525,1350,1514,,,,,,,-0.4594912,0.0116852,-0.0612653,0.00020636,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[6913, 7103]","```yaml
intervention:
  events: x
  group_size: 1,655
comparator:
  events: x
  group_size: 1,655
outcome:
  events: 
---
```yaml
intervention:
  events: x
  group_size: 1,512

comparator:
  events: x
  group_size: 1,514

outcome:
  events: 
---
",True
315,9842,4928400,Complication,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,5,22,7,20,,,,,,,-0.6047,0.4786,-0.4318,0.2474,,TRUE,4037,2288,TEST,[],"intervention:
  events: 5
  group_size: 22

comparator:
  events: 7
  group_size: 20

outcome:
  complication_rate: 22.7",False
333,5080,5617873,Serious adverse effects,Aripiprazole,Placbeo,binary,0,47,1,45,,,,,,,-1.9681,2.3302,-1.9034,2.2431,all means and std found in table 2,TRUE,7551,5383,TEST,[],"intervention:
  events: 0
  group_size: 47

comparator:
  events: 0
  group_size: 45

outcome:
  x
",False
400,2243,4678179,rate of adverse events,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),binary,4,53,2,53,,,,,,,0.73315252,0.79001601,0.69314718,0.71226415,Used numbers found in results section text.,TRUE,9517,6474,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: x
  group_size: 53

comparator:
  events: x
  group_size: 53",False
122,7936,4486927,The early virologic response (EVR),peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,86,94,82,93,,,,,,,0.3661,0.2397,0.0369,0.0024,,TRUE,14472,7883,TEST,"[6191, 1809]","```yaml
intervention:
  events: 86
  group_size: 94

comparator:
  events: 82
  group_size: 93

outcome:
  events: x
  
---
intervention:
  events: 23 (24.5)
  group_size: 94

comparator:
  events: 20 (21.5)
  group_size: 93
---
",True
654,13101,5976307,The incidence rate of myoclonus,etomidate,propofol based on midazolam,binary,10,62,1,62,,,,,,,2.46221524,1.13562421,2.30258509,1.06774194,found in table 3,TRUE,2560,2044,TEST,[],"intervention:
  events: 16.1
  group_size: 62

comparator:
  events: 1.6
  group_size: 62",False
40,6985,3169777,unexpected adverse events,macitentan doses of 25 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 0
  group_size: 14",False
139,3100,4830045,Embryo quality,Patients in the 3h group,Patients in the 20h group,binary,,74,,60,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear outcome measures.,FALSE,2530,2096,TEST,[],"intervention:
  events: Optimal embryo rate
  group_size: 74

comparator:
  events: Optimal embryo rate
  group_size: 60

outcome:
  events: N/A
  group",False
484,5713,3343759,history of myocardial infarction,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data are only in methods section.,FALSE,3838,2633,TEST,[],"```yaml
intervention:
  events: x
  group_size: 59

comparator:
  events: x
  group_size: 55

outcome:
  events: x
```",False
496,6488,5419060,Request-form errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,11,3973,,,,,,,0.05228567,0.17473861,0.05213706,0.17374765,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

intervention:
  events: 26
  group_size: 3973

comparator:
  events: 25
  group_size: 397",False
94,10167,4173437,Adverse effects,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,[],"intervention:
  events: 0
  group_size: 60

comparator:
  events: 0
  group_size: 60

outcome:
  events: x
  group_size: x",False
482,5524,4144850,E. coli contaminated water,Total Sanitation Campaign,Control,binary,310,404,331,403,,,,,,,-0.3321747,0.03077414,-0.0680244,0.00129032,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[6913, 7103]","```yaml
intervention:
  events: x
  group_size: 40
comparator:
  events: x
  group_size: 40
outcome:
  events: 310
  group
---
The text does not describe the presence of E. coli contaminated water, therefore I cannot complete the requested task.
---
",True
41,6985,3169777,unexpected adverse events,macitentan doses of 100 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 0
  group_size: 14",False
259,10575,5711682,rates of death,Genoss drug-eluting stent (DES),Promus Element,binary,1,38,0,39,,,,,,,1.1506,2.7186,1.1239,2.616,,TRUE,13148,4660,TEST,[],"intervention:
  events: 1
  group_size: 38

comparator:
  events: 0
  group_size: 39

outcome:
  x
",False
344,11082,5655920,Hypoglycaemia,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,TRUE,13081,5825,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 0
  group_size: x

comparator:
  events: 0
  group_size: x

outcome:
  events: x
",False
362,8714,5971365,clinically meaningful improvement at week 96 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,432,720,369,682,,,,,,,0.2409,0.0117,0.1034,0.0022,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,[],"intervention:
  events: 60.0
  group_size: 919

comparator:
  events: 54.1
  group_size: 922",False
65,1644,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)",adults with LBP with radicular pain (group C),binary,14,23,3,18,,,,,,,2.0513,0.5825,1.2953,0.3057,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 87
  group_size: 23

comparator:
  events: 16.7
  group_size: 18

",False
377,222,1475568,Baseline digoxin intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,15,59,12,64,,,,,,,0.3902,0.192,0.3045,0.1174,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,[],"```yaml
intervention:
  events: x
  group_size: 59
comparator:
  events: x
  group_size: 64

outcome:
  events: x
```",False
626,11906,3493722,poor compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,2,81,3,81,,,,,,,-0.4182041,0.85881207,-0.4054651,0.80864198,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,[],"intervention:
  events: 2.5%
  group_size: 85

comparator:
  events: 3.7%
  group_size: 84",False
691,13831,4210722,use of a reminder card,a separate reminder card 4 days before the appointment (IG3); reminder card together with the appointment letter (IG2);,no further reminder (IG1),binary,185,209,84,104,,,,,,,0.60721747,0.10897683,0.09159567,0.00291009,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[943, 7517]","```yaml
intervention:
  events: 4830
  group_size: 49
comparator:
  events: 843
  group_size: 81
outcome:
  use_
---
```yaml
intervention:
  events: x
  group_size: 92.2

comparator:
  events: x
  group_size: 81.0

outcome:
  events: Use of reminder
---
",True
342,11080,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,TRUE,13081,5825,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 0
  group_size: 122
comparator:
  events: 0
  group_size: 1150",False
625,11906,3493722,well compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,8,81,4,81,,,,,,,0.74649316,0.40168564,0.69314718,0.35030864,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,[],"intervention:
  events: 9.9%
  group_size: 85

comparator:
  events: 4.6%
  group_size: 84",False
124,7937,4486927,The SVR rates when the patients had BMI >30 kg/m2,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,10,19,6,12,,,,,,,0.1054,0.5444,0.0513,0.1307,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,"[6191, 1809]","```yaml
intervention:
  events: 52
  group_size: 94

comparator:
  events: 33
  group_size: 93

outcome:
  SVR rate when BMI
---
intervention:
  events: 23
  group_size: 94

comparator:
  events: 20
  group_size: 93
---
",True
546,8461,3263860,Severe hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,binary,3,73,5,71,,,,,,,-0.5696661,0.56277056,-0.5386052,0.5055502,,TRUE,3178,2587,TEST,[],"intervention:
  events: 3
  group_size: 69

comparator:
  events: 5
  group_size: 68",False
343,11081,5655920,Hypoglycaemia,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.02,TRUE,13081,5825,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: x
  group_size: 1639

comparator:
  events: x
  group_size: 1051

outcome:",False
631,12275,3936115,The number of diverticulitis clinical symptom occurrences during 12months,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,2,30,7,22,,,,,,,-1.8769173,0.7452381,-1.5629179,0.56406926,found in table 1,TRUE,2217,2016,TEST,[],"intervention:
  events: 2
  group_size: 30

comparator:
  events: 7
  group_size: 22",False
127,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H0 (saline),binary,11,49,21,50,,,,,,,-0.9169,0.1993,-0.6264,0.0981,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,[],"intervention:
  events: 5
  group_size: 50

comparator:
  events: 17
  group_size: 50

outcome:
  events: 17",False
13,12633,2667135,proportion of patients completed therapy,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,93,103,44,97,,,,,,,2.4161,0.1523,0.6884,0.0135,,TRUE,11722,8106,TEST,[7834],"```yaml
intervention:
  events: 90
  group_size: 103

comparator:
  events: 44
  group_size: 97

outcome:
  events: 9
---
",True
269,2991,3214395,laryngospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 46",group 3 involved bispectral index (BIS) of 36,binary,11,60,3,30,,,,,,,0.7033,0.4817,0.6061,0.3742,,TRUE,1201,996,TEST,[],"intervention:
  events: x
  group_size: 25
comparator:
  events: x
  group_size: 22
outcome:
  events: 0
  group_size: x",False
478,5525,4144850,Helminth infections,Total Sanitation Campaign,Control,binary,34,581,32,569,,,,,,,0.04217391,0.06435212,0.0397543,0.05718313,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,"[6913, 7103]","The text does not describe any data on helminth infections, therefore I cannot complete the requested task.
---
Sure, here is the requested YAML data:

```yaml
intervention:
  events: x
  group_size: 569
comparator:
  events: x
  group_size: 1,512
---
",True
178,10755,5086025,Binge eating,Intuitive Eating and Acceptance and Commitment Therapy,Control,binary,7,26,14,26,,,,,,,-1.1527,0.3503,-0.6931,0.1374,,TRUE,29049,17627,TEST,"[7478, 6988, 2606]","```yaml
intervention:
  events: x
  group_size: 20
comparator:
  events: x
  group_size: 20
outcome:
  events: 26
  group_
---
```yaml
intervention:
  events: x
  group_size: 37

comparator:
  events: x
  group_size: N/A

outcome:
  events: x
  group_size:
---
The text does not provide information about the contingency table for the requested data, therefore I cannot complete the request.
---
",True
405,2807,5781260,adverse events,lemon verbena extract,placebo,binary,,20,,20,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear numerical values.,FALSE,4385,3505,TEST,[],"intervention:
  events: 23
  group_size: 20

comparator:
  events: 18
  group_size: 20",False
641,12879,5830087,objective response rate (ORR),"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,29,48,19,23,,,,,,,-1.1352878,0.38974592,-0.3128499,0.02280274,found in table 2,TRUE,11942,10628,TEST,"[5035, 5030]","intervention:
  events: x
  group_size: 59

comparator:
  events: x
  group_size: 30

outcome:
  events: x
---
Sure, here is the requested YAML data:

intervention:
  events: x
  group_size: x

comparator:
  events: x
  group_size: x
---
",True
153,13479,5055753,The percentages of patients in the sedated scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,17,40,7,40,,,,,,,1.2483,0.2755,0.8873,0.1517,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,[],"intervention:
  events: 40
  group_size: 40

comparator:
  events: 40
  group_size: 40

outcome:
  group_size: 40",False
542,7795,3508963,Baseline characteristics - right kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,57,120,,,,,,,0.10008346,0.06675021,0.05129329,0.01754386,,TRUE,3561,2387,TEST,[],"intervention:
  events: x
  group_size: 120

comparator:
  events: x
  group_size: 120

outcome:
  events: x
  group_size: N",False
689,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),no further reminder (IG1),binary,94,102,84,104,,,,,,,1.02876872,0.19754306,0.13189607,0.00312375,found in text as fractions of group sizes,TRUE,10493,8112,TEST,"[943, 7517]","intervention:
  events: 120
  group_size: 73

comparator:
  events: 84
  group_size: 104
---
```yaml
intervention:
  events: x
  group_size: 92.2

comparator:
  events: x
  group_size: 81.0

outcome:
  events: 36
---
",True
501,6489,5419060,Preanalytical errors: CDC C,Phlebotomy training programme,Control,binary,10,2279,15,2321,,,,,,,-0.3892899,0.16754104,-0.3872037,0.16579703,,TRUE,9292,5719,TEST,[],"Sure, here is the requested contingency table:

intervention:
  events: 11
  group_size: 2321

comparator:
  events: 15
  group_size: 15",False
250,12425,5614421,The incidence of respiratory distress syndrome,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,42,402,41,388,,,,,,,-0.0127,0.0539,-0.0113,0.0431,,TRUE,25930,11480,TEST,"[7220, 4861]","```yaml
intervention:
  events: 42
  group_size: 406

comparator:
  events: 41
  group_size: 388

outcome:
  events: x
---
The text does not describe the incidence of respiratory distress syndrome, therefore I cannot complete the requested task.
---
",True
174,2796,5079604,The probability of relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,9,33,11,15,,,,,,,-1.9924,0.4937,-0.9891,0.1051,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,[],"```yaml
intervention:
  events: 5
  group_size: 17

comparator:
  events: 11
  group_size: 15

outcome:
  events: x
  group",False
64,1642,3309311,differences in the HIZ,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 87
  group_size: 23

comparator:
  events: 21.1
  group_size: 19

",False
37,6985,3169777,unexpected adverse events,macitentan doses of 0.2 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 0
  group_size: 14",False
38,6985,3169777,unexpected adverse events,macitentan doses of 1 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,[],"intervention:
  events: 0
  group_size: 6

comparator:
  events: 0
  group_size: 14",False
467,4434,5726464,Metabolic syndrome,Vitamin D plus calcium supplementation,Placebo,binary,9,66,11,75,,,,,,,-0.0848389,0.23518906,-0.0728373,0.17353535,,TRUE,6563,4244,TEST,[],"intervention:
  events: x
  group_size: 79

comparator:
  events: x
  group_size: 86

outcome:
  events: x",False
621,11904,3493722,eradication rate of H. pylori in ITT,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,85,72,84,,,,,,,-0.1681369,0.1827353,-0.0258207,0.00430393,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,[],"intervention:
  events: 83.5
  group_size: 85

comparator:
  events: 87.7
  group_size: 84",False
63,1642,3309311,differences in the annulus tear,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,TRUE,1437,1263,TEST,[],"Sure, here is the requested YAML data:

intervention:
  events: 87
  group_size: 23

comparator:
  events: 26.3
  group_size: 19

",False
538,7795,3508963,Baseline characteristics - hydronephrosis in right kidney,Intravenous lidocaine,Intravenous morphine,binary,57,120,53,120,,,,,,,0.13431725,0.06721017,0.07275935,0.01974512,,TRUE,3561,2387,TEST,[],"intervention:
  events: x
  group_size: 120

comparator:
  events: x
  group_size: 120

outcome:
  events: x
  group_size: N",False
84,13566,3687098,adverse event of constipation,sitagliptin 100 mg/day,comparator agent,binary,178,7726,124,6885,,,,,,,0.2514,0.014,0.2463,0.0134,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[4974, 5751]","intervention:
  events: 122
  group_size: 7,726

comparator:
  events: 811
  group_size: 6,885
---
intervention:
  events: 2.3
  group_size: 5,940

comparator:
  events: 1.8
  group_size: 5,122
---
",True
118,2984,4323894,Rate of complications,Mild-cooling or deep-cooling,No cooling,binary,,10,,13,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3049,2670,TEST,[],"intervention:
  events: 16
  group_size: 19

comparator:
  events: x
  group_size: 13

outcome:
  events: x
  group_size: x",False
182,4340,5122613,Adverse events,Digestion-resistant maltodextrin,Placebo,binary,0,33,0,33,,,,,,,0,4.0597,0,3.9412,Based on abstract.,TRUE,6184,3742,TEST,[],"```yaml
intervention:
  events: 6
  group_size: 33
comparator:
  events: 6
  group_size: 33
```",False
253,12427,5614421,"adverse infant outcomes, including serious infant composite outcome",vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,155,406,152,393,,,,,,,-0.0211,0.0212,-0.013,0.008,,TRUE,25930,11480,TEST,"[7220, 4861]","```yaml
intervention:
  events: x
  group_size: 406

comparator:
  events: x
  group_size: 393

outcome:
  events: x
```
---
The text does not describe any adverse infant outcomes, therefore I cannot complete the requested task.
---
",True
266,2787,2430617,adverse events,60 µg of YIC,placebo,binary,7,163,4,79,,,,,,,-0.1728,0.4126,-0.1647,0.3741,effects found in abstract and number of samples in text,TRUE,7987,4896,TEST,[],"intervention:
  events: 5
  group_size: 80

comparator:
  events: 3
  group_size: 79",False
36,6988,3169777,adverse event profile - headache,macitentan dose of 600 mg,placebo,binary,5,6,3,14,,,,,,,2.9087,1.6242,1.3581,0.2952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,[],"intervention:
  events: 2
  group_size: 6

comparator:
  events: 5
  group_size: 14",False
86,13568,3687098,The incidence rates of pancreatitis,sitagliptin 100 mg/day,comparator agent,binary,773,7726,689,6885,,,,,,,-0.0002,0.0031,-0.0002,0.0025,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,"[4974, 5751]","```yaml
intervention:
  events: 0
  group_size: 7,726

comparator:
  events: 0
  group_size: 6,885
```

The text does
---
```yaml
intervention:
  events: 0
  group_size: 100
comparator:
  events: 0
  group_size: 100

outcome:
  events: x
```
---
",True
642,12880,5830087,disease control rate,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,45,48,21,23,,,,,,,0.35667494,0.9031746,0.02643326,0.00552968,found in table 2,TRUE,11942,10628,TEST,"[5035, 5030]","Sure, here is the requested YAML data:

intervention:
  events: x
  group_size: 59

comparator:
  events: x
  group_size: 30

outcome:
  events:
---
Sure, here is the requested YAML data:

intervention:
  events: x
  group_size: x

comparator:
  events: x
  group_size: x
---
",True
